Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus

Biofilms formed by methicillin-resistant Staphylococcus aureus (MRSA) are one of the contributing factors to recurrent nosocomial infection in humans. There is currently no specific treatment targeting on biofilms in clinical trials approved by FDA, and antibiotics remain the primary therapeutic str...

Full description

Bibliographic Details
Main Authors: Zhi-Man Song, Jun-Liang Zhang, Kun Zhou, Lu-Ming Yue, Yu Zhang, Chang-Yun Wang, Kai-Ling Wang, Ying Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.709826/full
_version_ 1818590115887316992
author Zhi-Man Song
Zhi-Man Song
Zhi-Man Song
Jun-Liang Zhang
Kun Zhou
Lu-Ming Yue
Yu Zhang
Chang-Yun Wang
Chang-Yun Wang
Chang-Yun Wang
Kai-Ling Wang
Ying Xu
author_facet Zhi-Man Song
Zhi-Man Song
Zhi-Man Song
Jun-Liang Zhang
Kun Zhou
Lu-Ming Yue
Yu Zhang
Chang-Yun Wang
Chang-Yun Wang
Chang-Yun Wang
Kai-Ling Wang
Ying Xu
author_sort Zhi-Man Song
collection DOAJ
description Biofilms formed by methicillin-resistant Staphylococcus aureus (MRSA) are one of the contributing factors to recurrent nosocomial infection in humans. There is currently no specific treatment targeting on biofilms in clinical trials approved by FDA, and antibiotics remain the primary therapeutic strategy. In this study, two anthraquinone compounds isolated from a rare actinobacterial strain Kitasatospora albolonga R62, 3,8-dihydroxy-l-methylanthraquinon-2-carboxylic acid (1) and 3,6,8-trihydroxy-1-methylanthraquinone-2-carboxylic acid (2), together with their 10 commercial analogs 3–12 were evaluated for antibacterial and antibiofilm activities against MRSA, which led to the discovery of two potential antibiofilm anthraquinone compounds anthraquinone-2-carboxlic acid (6) and rhein (12). The structure-activity relationship analysis of these anthraquinones indicated that the hydroxyl group at the C-2 position of the anthraquinone skeleton played an important role in inhibiting biofilm formation at high concentrations, while the carboxyl group at the same C-2 position had a great influence on the antibacterial activity and biofilm eradication activity. The results of crystal violet and methyl thiazolyl tetrazolium staining assays, as well as scanning electron microscope and confocal scanning laser microscopy imaging of compounds 6 and 12 treatment groups showed that both compounds could disrupt preformed MRSA biofilms possibly by killing or dispersing biofilm cells. RNA-Seq was subsequently used for the preliminary elucidation of the mechanism of biofilm eradication, and the results showed upregulation of phosphate transport-related genes in the overlapping differentially expressed genes of both compound treatment groups. Herein, we propose that anthraquinone compounds 6 and 12 could be considered promising candidates for the development of antibiofilm agents.
first_indexed 2024-12-16T09:51:25Z
format Article
id doaj.art-81d8752238e549ea82fb82079948c80e
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-16T09:51:25Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-81d8752238e549ea82fb82079948c80e2022-12-21T22:36:03ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-09-011210.3389/fmicb.2021.709826709826Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureusZhi-Man Song0Zhi-Man Song1Zhi-Man Song2Jun-Liang Zhang3Kun Zhou4Lu-Ming Yue5Yu Zhang6Chang-Yun Wang7Chang-Yun Wang8Chang-Yun Wang9Kai-Ling Wang10Ying Xu11Shenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaDepartment of Chemistry, The University of Hong Kong, Pokfulam, Hong Kong, ChinaCollege of Pharmacy, Institute of Materia Medica, Dali University, Dali, ChinaShenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaShenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaShenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaShenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaKey Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, ChinaLaboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao, ChinaInstitute of Evolution and Marine Biodiversity, Ocean University of China, Qingdao, ChinaCollege of Pharmacy, Institute of Materia Medica, Dali University, Dali, ChinaShenzhen Key Laboratory of Marine Bioresource and Eco-Environmental Science, Shenzhen Engineering Laboratory for Marine Algal Biotechnology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaBiofilms formed by methicillin-resistant Staphylococcus aureus (MRSA) are one of the contributing factors to recurrent nosocomial infection in humans. There is currently no specific treatment targeting on biofilms in clinical trials approved by FDA, and antibiotics remain the primary therapeutic strategy. In this study, two anthraquinone compounds isolated from a rare actinobacterial strain Kitasatospora albolonga R62, 3,8-dihydroxy-l-methylanthraquinon-2-carboxylic acid (1) and 3,6,8-trihydroxy-1-methylanthraquinone-2-carboxylic acid (2), together with their 10 commercial analogs 3–12 were evaluated for antibacterial and antibiofilm activities against MRSA, which led to the discovery of two potential antibiofilm anthraquinone compounds anthraquinone-2-carboxlic acid (6) and rhein (12). The structure-activity relationship analysis of these anthraquinones indicated that the hydroxyl group at the C-2 position of the anthraquinone skeleton played an important role in inhibiting biofilm formation at high concentrations, while the carboxyl group at the same C-2 position had a great influence on the antibacterial activity and biofilm eradication activity. The results of crystal violet and methyl thiazolyl tetrazolium staining assays, as well as scanning electron microscope and confocal scanning laser microscopy imaging of compounds 6 and 12 treatment groups showed that both compounds could disrupt preformed MRSA biofilms possibly by killing or dispersing biofilm cells. RNA-Seq was subsequently used for the preliminary elucidation of the mechanism of biofilm eradication, and the results showed upregulation of phosphate transport-related genes in the overlapping differentially expressed genes of both compound treatment groups. Herein, we propose that anthraquinone compounds 6 and 12 could be considered promising candidates for the development of antibiofilm agents.https://www.frontiersin.org/articles/10.3389/fmicb.2021.709826/fullanthraquinonesantibiofilm agentsKitasatospora albolongaRNA-SeqantibioticsPst system
spellingShingle Zhi-Man Song
Zhi-Man Song
Zhi-Man Song
Jun-Liang Zhang
Kun Zhou
Lu-Ming Yue
Yu Zhang
Chang-Yun Wang
Chang-Yun Wang
Chang-Yun Wang
Kai-Ling Wang
Ying Xu
Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
Frontiers in Microbiology
anthraquinones
antibiofilm agents
Kitasatospora albolonga
RNA-Seq
antibiotics
Pst system
title Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
title_full Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
title_fullStr Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
title_full_unstemmed Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
title_short Anthraquinones as Potential Antibiofilm Agents Against Methicillin-Resistant Staphylococcus aureus
title_sort anthraquinones as potential antibiofilm agents against methicillin resistant staphylococcus aureus
topic anthraquinones
antibiofilm agents
Kitasatospora albolonga
RNA-Seq
antibiotics
Pst system
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.709826/full
work_keys_str_mv AT zhimansong anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT zhimansong anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT zhimansong anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT junliangzhang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT kunzhou anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT lumingyue anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT yuzhang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT changyunwang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT changyunwang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT changyunwang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT kailingwang anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus
AT yingxu anthraquinonesaspotentialantibiofilmagentsagainstmethicillinresistantstaphylococcusaureus